These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18226797)

  • 41. Relationships Between the Cumulative Incidences of Long-term Complications in Type 1 Diabetes: The DCCT/EDIC Study.
    Bebu I; Braffett BH; de Boer IH; Aiello LP; Bantle JP; Lorenzi GM; Herman WH; Gubitosi-Klug RA; Perkins BA; Lachin JM; Molitch ME
    Diabetes Care; 2023 Feb; 46(2):361-368. PubMed ID: 36520643
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimal optical coherence tomography-based measures in the diagnosis of clinically significant macular edema: retinal volume vs foveal thickness.
    Campbell RJ; Coupland SG; Buhrmann RR; Kertes PJ
    Arch Ophthalmol; 2007 May; 125(5):619-23. PubMed ID: 17502499
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The relation of retinal vessel caliber to the incidence and progression of diabetic retinopathy: XIX: the Wisconsin Epidemiologic Study of Diabetic Retinopathy.
    Klein R; Klein BE; Moss SE; Wong TY; Hubbard L; Cruickshanks KJ; Palta M
    Arch Ophthalmol; 2004 Jan; 122(1):76-83. PubMed ID: 14718299
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus.
    Valmadrid CT; Klein R; Moss SE; Klein BE
    Arch Intern Med; 2000 Apr; 160(8):1093-100. PubMed ID: 10789601
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of scanning laser ophthalmoscope microperimetry in clinically significant macular edema in type 2 diabetes mellitus.
    Mori F; Ishiko S; Kitaya N; Hikichi T; Sato E; Takamiya A; Yoshida A
    Jpn J Ophthalmol; 2002; 46(6):650-5. PubMed ID: 12543192
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial.
    Haritoglou C; Gerss J; Sauerland C; Kampik A; Ulbig MW;
    Lancet; 2009 Apr; 373(9672):1364-71. PubMed ID: 19376452
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema.
    Klein R; Klein BE; Moss SE; Cruickshanks KJ
    Ophthalmology; 1995 Jan; 102(1):7-16. PubMed ID: 7831044
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Macular thickness measured by optical coherence tomography (OCT) in diabetic patients.
    Lattanzio R; Brancato R; Pierro L; Bandello F; Iaccher B; Fiore T; Maestranzi G
    Eur J Ophthalmol; 2002; 12(6):482-7. PubMed ID: 12510717
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Three different phenotypes of mild nonproliferative diabetic retinopathy with different risks for development of clinically significant macular edema.
    Nunes S; Ribeiro L; Lobo C; Cunha-Vaz J
    Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4595-604. PubMed ID: 23745006
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential Impact of Unilateral and Bilateral Classifications of Diabetic Retinopathy and Diabetic Macular Edema on Vision-Related Quality of Life.
    Man RE; Fenwick EK; Sabanayagam C; Li LJ; Tey CS; Soon HJ; Cheung GC; Tan GS; Wong TY; Lamoureux EL
    Invest Ophthalmol Vis Sci; 2016 Sep; 57(11):4655-60. PubMed ID: 27603726
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Microaneurysm turnover is a biomarker for diabetic retinopathy progression to clinically significant macular edema: findings for type 2 diabetics with nonproliferative retinopathy.
    Nunes S; Pires I; Rosa A; Duarte L; Bernardes R; Cunha-Vaz J
    Ophthalmologica; 2009; 223(5):292-7. PubMed ID: 19372723
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy.
    Klein BE; Klein R; McBride PE; Cruickshanks KJ; Palta M; Knudtson MD; Moss SE; Reinke JO
    Arch Intern Med; 2004 Sep; 164(17):1917-24. PubMed ID: 15451768
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Relationship between macular morphology and visual function in diabetic macular edema].
    Jin HY; Liu HY; Liu K; Sun XD; Ren QS; Xu X
    Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(7):524-7. PubMed ID: 23660322
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Utilization of eye health services and diabetic retinopathy: a cross-sectional study among persons living with diabetes visiting a tertiary eye care facility in Ghana.
    Akrofi B; Tetteh J; Amissah-Arthur KN; Buxton ENA; Yawson A
    BMC Health Serv Res; 2021 Jun; 21(1):590. PubMed ID: 34147100
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sex hormones and DHEA-SO4 in relation to ischemic heart disease mortality in diabetic subjects. The Wisconsin Epidemiologic Study of Diabetic Retinopathy.
    Haffner SM; Moss SE; Klein BE; Klein R
    Diabetes Care; 1996 Oct; 19(10):1045-50. PubMed ID: 8886548
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Digoxin does not accelerate progression of diabetic retinopathy.
    Gardner TW; Klein R; Moss SE; Ferris FL; Remaley NA
    Diabetes Care; 1995 Feb; 18(2):237-40. PubMed ID: 7729304
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SAVE: a grading protocol for clinically significant diabetic macular oedema based on optical coherence tomography and fluorescein angiography.
    Bolz M; Lammer J; Deak G; Pollreisz A; Mitsch C; Scholda C; Kundi M; Schmidt-Erfurth U;
    Br J Ophthalmol; 2014 Dec; 98(12):1612-7. PubMed ID: 25091952
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy.
    Klein R; Klein BE; Moss SE; Cruickshanks KJ
    Arch Ophthalmol; 1994 Sep; 112(9):1217-28. PubMed ID: 7619101
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of Statin Therapy With Prevention of Vision-Threatening Diabetic Retinopathy.
    Kang EY; Chen TH; Garg SJ; Sun CC; Kang JH; Wu WC; Hung MJ; Lai CC; Cherng WJ; Hwang YS
    JAMA Ophthalmol; 2019 Apr; 137(4):363-371. PubMed ID: 30629109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A cohort study of the relationship of diabetic retinopathy to blood pressure.
    Klein BE; Klein R; Moss SE; Palta M
    Arch Ophthalmol; 1995 May; 113(5):601-6. PubMed ID: 7748130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.